Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes

Current Japanese encephalitis vaccines are derived from strains of genotype III, yet heterologous genotypes are emerging in endemic areas. Inactivated vaccines given to European travelers were found to elicit protective levels of neutralizing antibodies against heterologous strains of genotypes I–IV...

Descripción completa

Detalles Bibliográficos
Autores principales: Erra, Elina O., Askling, Helena Hervius, Yoksan, Sutee, Rombo, Lars, Riutta, Jukka, Vene, Sirkka, Lindquist, Lars, Vapalahti, Olli, Kantele, Anu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526254/
https://www.ncbi.nlm.nih.gov/pubmed/23074319
http://dx.doi.org/10.1093/cid/cis883
_version_ 1782253528923766784
author Erra, Elina O.
Askling, Helena Hervius
Yoksan, Sutee
Rombo, Lars
Riutta, Jukka
Vene, Sirkka
Lindquist, Lars
Vapalahti, Olli
Kantele, Anu
author_facet Erra, Elina O.
Askling, Helena Hervius
Yoksan, Sutee
Rombo, Lars
Riutta, Jukka
Vene, Sirkka
Lindquist, Lars
Vapalahti, Olli
Kantele, Anu
author_sort Erra, Elina O.
collection PubMed
description Current Japanese encephalitis vaccines are derived from strains of genotype III, yet heterologous genotypes are emerging in endemic areas. Inactivated vaccines given to European travelers were found to elicit protective levels of neutralizing antibodies against heterologous strains of genotypes I–IV.
format Online
Article
Text
id pubmed-3526254
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-35262542012-12-19 Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes Erra, Elina O. Askling, Helena Hervius Yoksan, Sutee Rombo, Lars Riutta, Jukka Vene, Sirkka Lindquist, Lars Vapalahti, Olli Kantele, Anu Clin Infect Dis Brief Report Current Japanese encephalitis vaccines are derived from strains of genotype III, yet heterologous genotypes are emerging in endemic areas. Inactivated vaccines given to European travelers were found to elicit protective levels of neutralizing antibodies against heterologous strains of genotypes I–IV. Oxford University Press 2013-01-15 2012-10-16 /pmc/articles/PMC3526254/ /pubmed/23074319 http://dx.doi.org/10.1093/cid/cis883 Text en © The Author 2012. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Report
Erra, Elina O.
Askling, Helena Hervius
Yoksan, Sutee
Rombo, Lars
Riutta, Jukka
Vene, Sirkka
Lindquist, Lars
Vapalahti, Olli
Kantele, Anu
Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes
title Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes
title_full Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes
title_fullStr Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes
title_full_unstemmed Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes
title_short Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes
title_sort cross-protective capacity of japanese encephalitis (je) vaccines against circulating heterologous je virus genotypes
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526254/
https://www.ncbi.nlm.nih.gov/pubmed/23074319
http://dx.doi.org/10.1093/cid/cis883
work_keys_str_mv AT erraelinao crossprotectivecapacityofjapaneseencephalitisjevaccinesagainstcirculatingheterologousjevirusgenotypes
AT asklinghelenahervius crossprotectivecapacityofjapaneseencephalitisjevaccinesagainstcirculatingheterologousjevirusgenotypes
AT yoksansutee crossprotectivecapacityofjapaneseencephalitisjevaccinesagainstcirculatingheterologousjevirusgenotypes
AT rombolars crossprotectivecapacityofjapaneseencephalitisjevaccinesagainstcirculatingheterologousjevirusgenotypes
AT riuttajukka crossprotectivecapacityofjapaneseencephalitisjevaccinesagainstcirculatingheterologousjevirusgenotypes
AT venesirkka crossprotectivecapacityofjapaneseencephalitisjevaccinesagainstcirculatingheterologousjevirusgenotypes
AT lindquistlars crossprotectivecapacityofjapaneseencephalitisjevaccinesagainstcirculatingheterologousjevirusgenotypes
AT vapalahtiolli crossprotectivecapacityofjapaneseencephalitisjevaccinesagainstcirculatingheterologousjevirusgenotypes
AT kanteleanu crossprotectivecapacityofjapaneseencephalitisjevaccinesagainstcirculatingheterologousjevirusgenotypes

Ejemplares similares